Found 8 matching trials
HSK7653 Metformin Add-on Study in Patients With Type 2 Diabetes Mellitus PHASE3 The purpose of this study is to assess the efficacy of HSK7653 (as an add-o...
Show More Location
Peking University People's Hospital
Learn More & Join Trial
HSK7653 Treatment in Patients With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise PHASE3 The purpose of this study is to assess the efficacy of HSK7653 (as monother...
Show More Location
Peking University People's Hospital
Learn More & Join Trial
Multiple-dose Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Pharmacodynamics of HSK7653 in T2DM PHASE2 To evaluate the safety, tolerability and pharmacokinetic (PK)/pharmacodynam...
Show More Location
Peking university people's hospital
Learn More & Join Trial
A Multicenter, Randomized, Open-Label, Parallel-Controlled Clinical Study Comparing the Efficacy and Safety of Cofrogliptin Versus Acarbose in Drug-NaΓ―ve Patients With Type 2 Diabetes NA This study will compare the effect and safety of cofrogliptin (HSK7653) wit...
Show More Location
He'nan Provincial People's Hospital
Learn More & Join Trial
Single Escalating Dose Study Of HSK7653 In Healthy Subjects PHASE1 To evaluate the safety, tolerability, pharmacokinetic (PK) and pharmacodyna...
Show More Location
Peking Union Medical College Hospital
Learn More & Join Trial
A Study to Evaluate the Pharmacokinetics of HSK7653 in Subjects With Renal Impairment PHASE1 This is an open-label, single-dose study to evaluate the pharmacokinetics, ...
Show More Location
Beijing Jishuitan Hospital
Learn More & Join Trial
HSK7653 in Chinese Patients with Impaired Glucose Tolerance PHASE2 This study is being done to evaluate the efficacy, safety of HSK7653 in chi...
Show More Location
Emergency General Hospital
Learn More & Join Trial
A Study on Switching From Daily DPP-4 Inhibitor to HSK7653 in Type 2 Diabetes Patients PHASE2 To assess the effectiveness of HSK7653 tablets following the substitution o...
Show More Location
Chu Hsien-I Memorial Hospital, Tianjin Medical University
Learn More & Join Trial